Business Context and Reporting Period
Company: NovaLifeStyle, Inc. (Note: Request metadata listed "Xmax Inc.", but the filing identifies NovaLifeStyle, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: September 3, 2025
Event Date: September 4, 2025 (Closing of Offering)
Context: The Company entered into a Securities Purchase Agreement and closed a best-efforts public offering of common stock and warrants.
Key Financial Metrics
| Metric | Value |
|---|---|
| Gross Proceeds | Approximately $9.0 million |
| Net Proceeds | Approximately $8.15 million |
| Shares Issued | 9,836,054 shares of Common Stock |
| Warrants Issued | 19,672,108 Warrants (2 per share) |
| Combined Purchase Price | $0.915 per Share and accompanying Warrants |
| Warrant Exercise Price | $1.098 per share |
| Placement Agent Fees | 7.0% cash fee + 1.0% expense allowance + $150,000 out-of-pocket |
Note: This filing does not provide revenue, profit, cash flow, margins, or debt figures for the Company's operations.
Material Changes
- Capital Structure: Significant dilution occurred with the issuance of nearly 9.84 million new shares and 19.67 million warrants.
- Liquidity: The Company raised approximately $8.15 million in net cash proceeds.
- Restrictions: A 90-day lock-up period was imposed on officers, directors, and the Company regarding the issuance and sale of securities.
Outlook, Management Commentary, and Risks
- Use of Proceeds: Net proceeds will be used for working capital, marketing expenditures, repayment of short-term debt, and capital expenditures.
- Warrant Terms: Warrants are immediately exercisable and expire five years from issuance.
- Regulatory Status: The offering was conducted pursuant to a Registration Statement on Form S-1 declared effective on August 27, 2025.
- Risks: The filing does not explicitly detail new risks beyond standard offering terms and lock-up restrictions.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-offering to assess dilution impact.
- Confirm the specific amount of "short-term debt" intended for repayment with the proceeds.
- Review the full Placement Agency Agreement (Exhibit 1.1) for additional compensation terms or conditions.
- Check the Company's recent 10-K or 10-Q for baseline financial health, as this 8-K contains no operational financial data.